SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-080069
Filing Date
2013-11-01
Accepted
2013-11-01 16:15:12
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-18820_110q.htm 10-Q 1234977
2 EX-10.19 a13-18820_1ex10d8.htm EX-10.8 623433
3 EX-31.1 a13-18820_1ex31d1.htm EX-31.1 13026
4 EX-31.2 a13-18820_1ex31d2.htm EX-31.2 13767
5 EX-32 a13-18820_1ex32.htm EX-32 11682
  Complete submission text file 0001104659-13-080069.txt   10114088

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thrx-20130930.xml EX-101.INS 1192113
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrx-20130930.xsd EX-101.SCH 93282
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrx-20130930_cal.xml EX-101.CAL 60163
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT thrx-20130930_lab.xml EX-101.LAB 1515406
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrx-20130930_pre.xml EX-101.PRE 760941
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrx-20130930_def.xml EX-101.DEF 534654
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 131186077
SIC: 2834 Pharmaceutical Preparations